FDA Advisory Committee votes in favour of the clinical
U.S. FDA’s Oncologic Drugs Advisory Committee voted 11 to 2 in favour of the clinical benefit of the phase III POLARIX study of Polivy in combination with......
Roche launches two new antibodies to identify key clinical
Recent advances in cancer genomics have deepened the medical community’s understanding of the molecular alterations in brain tumours, more precisely......
![[Ad hoc announcement pursuant to Art. 53 LR] Transaction in](http://globenewswire.vietreader.com/thumb/190x300/2023-02/ad-hoc-announcement-pursuant-to-art-53-lr-transaction-in-1.png)
[Ad hoc announcement pursuant to Art. 53 LR] Transaction in
Basel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Roche Long Term Foundation acquired 540’000 Roche bearer shares at......
European Commission approves label expansion of Roche’s
Hemlibra, already approved for severe haemophilia A in the EU, will now also provide an effective and convenient prophylactic treatment option for people......